Getting medical devices to market requires an innovative approach that pulls together real-time communication and seamless tech integration.
Learn more.
While J&J, Abbott and Boston Scientific have all said the White House’s tariff policies will cost them hundreds of millions of dollars, yearly forecasts have remained in place — or even increased.
McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of Insulet for three years, resigned on Monday but will work as a consultant.
Product liability coverage is an essential tool for safeguarding your business’s balance sheet and reputation. Explore how to consider risk management partners for your life sciences business in this playbook.
